Griffin JD - Search Results

1

Epidermal growth factor-independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progression.

Jiang J, Greulich H, Jänne PA, Sellers WR, Meyerson M, Griffin JD. Jiang J, et al. Among authors: griffin jd. Cancer Res. 2005 Oct 1;65(19):8968-74. doi: 10.1158/0008-5472.CAN-05-1829. Cancer Res. 2005. PMID: 16204070

2

Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

Weisberg E, Boulton C, Kelly LM, Manley P, Fabbro D, Meyer T, Gilliland DG, Griffin JD. Weisberg E, et al. Among authors: griffin jd. Cancer Cell. 2002 Jun;1(5):433-43. doi: 10.1016/s1535-6108(02)00069-7. Cancer Cell. 2002. PMID: 12124173 Free article.

3

Critical role for Gab2 in transformation by BCR/ABL.

Sattler M, Mohi MG, Pride YB, Quinnan LR, Malouf NA, Podar K, Gesbert F, Iwasaki H, Li S, Van Etten RA, Gu H, Griffin JD, Neel BG. Sattler M, et al. Among authors: griffin jd. Cancer Cell. 2002 Jun;1(5):479-92. doi: 10.1016/s1535-6108(02)00074-0. Cancer Cell. 2002. PMID: 12124177 Free article.

4

The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment.

Lin B, Podar K, Gupta D, Tai YT, Li S, Weller E, Hideshima T, Lentzsch S, Davies F, Li C, Weisberg E, Schlossman RL, Richardson PG, Griffin JD, Wood J, Munshi NC, Anderson KC. Lin B, et al. Among authors: griffin jd. Cancer Res. 2002 Sep 1;62(17):5019-26. Cancer Res. 2002. PMID: 12208756

5

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.

Armstrong SA, Kung AL, Mabon ME, Silverman LB, Stam RW, Den Boer ML, Pieters R, Kersey JH, Sallan SE, Fletcher JA, Golub TR, Griffin JD, Korsmeyer SJ. Armstrong SA, et al. Among authors: griffin jd. Cancer Cell. 2003 Feb;3(2):173-83. doi: 10.1016/s1535-6108(03)00003-5. Cancer Cell. 2003. PMID: 12620411 Free article.

6

Molecular mechanisms of transformation by the BCR-ABL oncogene.

Sattler M, Griffin JD. Sattler M, et al. Among authors: griffin jd. Semin Hematol. 2003 Apr;40(2 Suppl 2):4-10. doi: 10.1053/shem.2003.50034. Semin Hematol. 2003. PMID: 12783368 Review.

7

c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.

Ma PC, Kijima T, Maulik G, Fox EA, Sattler M, Griffin JD, Johnson BE, Salgia R. Ma PC, et al. Among authors: griffin jd. Cancer Res. 2003 Oct 1;63(19):6272-81. Cancer Res. 2003. PMID: 14559814

8

FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins.

Scheijen B, Ngo HT, Kang H, Griffin JD. Scheijen B, et al. Among authors: griffin jd. Oncogene. 2004 Apr 22;23(19):3338-49. doi: 10.1038/sj.onc.1207456. Oncogene. 2004. PMID: 14981546

9

Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML.

Jiang J, Paez JG, Lee JC, Bo R, Stone RM, DeAngelo DJ, Galinsky I, Wolpin BM, Jonasova A, Herman P, Fox EA, Boggon TJ, Eck MJ, Weisberg E, Griffin JD, Gilliland DG, Meyerson M, Sellers WR. Jiang J, et al. Among authors: griffin jd. Blood. 2004 Sep 15;104(6):1855-8. doi: 10.1182/blood-2004-02-0712. Epub 2004 Jun 3. Blood. 2004. PMID: 15178581 Free article.

10

Modulation of Notch signaling by mastermind-like (MAML) transcriptional co-activators and their involvement in tumorigenesis.

Wu L, Griffin JD. Wu L, et al. Among authors: griffin jd. Semin Cancer Biol. 2004 Oct;14(5):348-56. doi: 10.1016/j.semcancer.2004.04.014. Semin Cancer Biol. 2004. PMID: 15288260

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

540 results

Search Page